Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical analysis of the effects of azole antifungal agents on the anticoagulant activity of warfarin.

Medicine - 13 Nov 2020

Chen Wenjun, Wu Tingting, Jiang Shaojun, Lv Meina, Fu Jinglan, Xia Xiaotong, Zhang Jinhua

Abstract excerpt

To investigate the frequency and degree of azole antifungal agents that influence the anticoagulant activity of warfarin to reduce the potential bleeding risk and provide a reference for rational administration of warfarin in clinics.Patients with an abnormal international normalized ratio (INR; INR ≥ 4.5) and treated with warfarin plus azole antifungal agents were screened from February 2011 to July 2016, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Antifungal Agents
Share to Azoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Drug Therapy, Combination

Share to International Normalized Ratio

Share to Metabolism, Inborn Errors

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 33181661
DOI: 10.1097/MD.0000000000022987
PMCID: PMC7668448

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical analysis of the effects of azole antifungal agents on the anticoagulant activity of warfarin.PMID 33181661Read ↗

[CYP2C19 genetic polymorphism and monitoring voriconazole plasma concentrations in the treatment and prevention of invasive fungal disease for hematological patients].Semantic proximity Read ↗

Exploring the molecular mechanism of azole resistance in Aspergillus fumigatus.Semantic proximity Read ↗

Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicineSemantic proximity Read ↗

Medically Important Fungi Respond to Azole Drugs: An UpdateSemantic proximity Read ↗

Gastrointestinal Bleeding During Direct Oral Anticoagulants Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of PolypharmacySemantic proximity Read ↗

Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?Semantic proximity Read ↗

Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.Semantic proximity Read ↗

Therapeutic drug monitoring of voriconazole.Semantic proximity Read ↗

Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Semantic proximity Read ↗

Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.Semantic proximity Read ↗

Tacrolimus as a Promising Drug for Epistaxis and Gastro Intestinal Bleeding in HHTSemantic proximity Read ↗

Unlocking New Strategies: Reversing Fluconazole Resistance In Candida Species With Efflux Pump Inhibitors Like Aspirin And IbuprofenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.